Sec Form 13D Filing - Trilogy Equity Partners, LLC filing for - 2025-10-15

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
Represents the following securities held directly by the Reporting Person: (i) 1,567,468 shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Common Stock"), (ii) 158,309 shares of Common Stock issuable upon conversion of Series A Convertible Preferred Stock, pursuant to an investment agreement entered into as of February 17, 2023 (the "2023 Investment Agreement"), and (iii) 296,401 shares of Common Stock issuable upon the conversion of Series B Convertible Preferred Stock, pursuant to an investment agreement entered into as of February 25, 2024 (the "2024 Investment Agreement"). Calculations of the percentage of the shares of Common Stock beneficially owned assumes (i) 22,788,420 shares of Common Stock outstanding as of October 10, 2025, as reported in the Issuer's Current Report on Form 8-K filed with the Securities Exchange Commission (the "SEC") on October 14, 2025, (ii) 158,309 shares of Common Stock issuable upon the conversion of Series A Convertible Preferred Stock purchased by the Reporting Person pursuant to the 2023 Investment Agreement, and (iii) 296,401 shares of Common Stock issuable upon the conversion of Series B Convertible Preferred Stock purchased by the Reporting Person pursuant to the 2024 Investment Agreement described herein.


SCHEDULE 13D

 
Trilogy Equity Partners, LLC
 
Signature:/s/ Amy McCullough
Name/Title:Amy McCullough, President, Managing Director
Date:10/15/2025
primary_doc.xml